Advancing Regulatory Science Expanded and improved approach to identifying surface protein markers could support development of therapies with human bone marrow multipotent stromal cells An FDA proteomic analysis of cell - Stromal cell - Document - PDFSEARCH.IO

First Page	Meta Content
	Advancing Regulatory Science Expanded and improved approach to identifying surface protein markers could support development of therapies with human bone marrow multipotent stromal cells An FDA proteomic analysis of cell Add to Reading List Open Document File Size: 262,45 KB Share Result on Facebook Organization FDA / Center for Biologics Evaluation and Research / US Food and Drug Administration / Division of Cellular and Gene Therapies / / Person Michail A. Altermana / Samuel T. Mindayea / Jessica Lo Surdob / Bethesda / Steven R. Bauerb / / PublishedMedium Proteomics / / Technology Proteomics / Biotechnology / stem cells / / SocialTag Biotechnology Lymphocytes Cell biology Mesenchymal stem cell Cellular differentiation B cell Cell therapy Biology Stem cells Developmental biology

Advancing Regulatory Science Expanded and improved approach to identifying surface protein markers could support development of therapies with human bone marrow multipotent stromal cells An FDA proteomic analysis of cellAdd to Reading List